Findings aid antiviral drug discovery
Many viral infections, such as the common cold, cause mild illnesses that the body’s immune system eventually defeats. But when viruses cause severe disease, doctors have few options for effective treatment.
Studying mice with a variety of viral infections, scientists at Washington University School of Medicine in St. Louis have demonstrated a way to dial up the body’s innate immune defenses while simultaneously attacking a protein that many viruses rely on to replicate.
The findings, published Oct. 19 in Nature Immunology, reveal previously unknown weapons in the body’s antiviral immune arsenal and provide guidelines for designing drugs that could be effective against a broad range of viruses. The strategy involves enhancing the body’s interferon signaling system, long understood to be a vital part of antiviral defenses.
“We’ve discovered a new component of the interferon system,” said senior author Michael J. Holtzman, MD, the Selma and Herman Seldin Professor of Medicine. “It does something that other components don’t do, and it works on both sides of the fence: It dials up the body’s internal genes that fight viruses, and it attacks viral proteins directly.”
Holtzman and lead author Yong Zhang, PhD, an instructor in pulmonary medicine, suspect that the researchers’ one-two punch against the virus may explain the large difference in survival rates between control mice and mice genetically engineered to have increased signaling in their interferon systems.
When infected with encephalomyocarditis virus, which causes severe damage to vital organs including the brain, heart and pancreas, 97 percent of the genetically engineered mice survived, compared with none of the control mice. Even when the concentration of the injected virus was increased 100-fold, 82 percent of the genetically altered mice survived. And at 100-fold lower concentrations, all genetically engineered mice survived the infection, compared with only 25-28 percent of the control mice.
Holtzman pointed out that past research by other groups has shown that increasing the amount of interferon directly results in some improvements in fighting viruses, but not to the same extent as the current work. In addition, more modest improvements shown by other investigators usually are accompanied by autoimmune problems resulting from the chronically activated immune response. Despite the strong antiviral immune response seen in the new study, Holtzman and his colleagues reported no evidence of autoimmune disease in these mice.
Read more: Study reveals new, potent way to boost immunity and fight viruses
The Latest on: Antiviral immune response
[google_news title=”” keyword=”antiviral immune response” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antiviral immune response
- ENA Respiratory receives US patent covering INNA-051, a first-in-class antiviral innate immunomodulatoron May 10, 2024 at 2:30 am
ENA Respiratory receives US patent covering INNA-051, a first-in-class antiviral innate immunomodulator: Melbourne, Australia Friday, May 10, 2024, 15:00 Hrs [IST] ENA Respiratory ...
- Research finds genetic variation that could lead to increased risk of viral infectionson May 9, 2024 at 11:44 am
A new study, led by Jesmond Dalli, professor of molecular pharmacology at Queen Mary University of London, has found that people with a genetic mutation that leads to a reduction in a protein called ...
- Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Updateon May 9, 2024 at 6:45 am
Top-line results from the ongoing investigator-initiated Bateman Horne Center Long-COVID phase 2 featuring valacyclovir and celecoxib (IMC-2) ...
- Viruses Keep Mice from Stressing Outon May 8, 2024 at 5:00 pm
They showed that stress altered the expression of genes related to fear and stress responses, immune processes, viral activities like replication, and neurotransmitter levels. Transplanting mice with ...
- Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnosticson May 7, 2024 at 5:00 am
Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, today announced expansion of their host immune ...
- Gut-Brain Treatment Goes Viralon May 6, 2024 at 9:16 am
It’s not just gut bacteria that connect our guts to our brains. Tiny viruses also have an outsized role to play.
- Viral post mistakes aluminum guidelines on IV feeding for vaccine limit | Fact checkon April 30, 2024 at 10:16 am
The FDA limit in question is for the amount of aluminum allowed in IV nutrition for infants and people with kidney issues, not vaccines.
- Immune key to chronic viral infections discoveredon April 29, 2024 at 7:59 pm
One of the remaining mysteries of the human immune system is why a certain cell, called a B cell, which retains a memory for past infections -- ensuring we fight off diseases we have experienced ...
- ENA Respiratory Announces FDA IND Clearance for its Prophylactic Intranasal INNA-051 - a First-in-Class Antiviral Innate Immunomodulatoron April 29, 2024 at 1:01 am
ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated with respiratory viral infections in at-risk populations, ...
- Can Neosporin in the Nose Help Prevent Viral Infections?on April 26, 2024 at 11:19 am
A small study recently published in PNAS presents a similar, if lower-tech, idea. Coating the inside of the nose with the over-the-counter antibiotic ointment Neosporin seems to trigger an immune ...
via Bing News